nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—SIRT5—forebrain—narcolepsy	0.0248	0.114	CbGeAlD
Suramin—SIRT1—forebrain—narcolepsy	0.0206	0.0944	CbGeAlD
Suramin—SIRT5—medulla oblongata—narcolepsy	0.0179	0.0823	CbGeAlD
Suramin—P2RX4—medulla oblongata—narcolepsy	0.0169	0.0778	CbGeAlD
Suramin—SIRT1—medulla oblongata—narcolepsy	0.0149	0.0682	CbGeAlD
Suramin—RYR1—medulla oblongata—narcolepsy	0.0137	0.063	CbGeAlD
Suramin—SIRT1—midbrain—narcolepsy	0.0136	0.0623	CbGeAlD
Suramin—RYR1—midbrain—narcolepsy	0.0125	0.0576	CbGeAlD
Suramin—SIRT5—brain—narcolepsy	0.0103	0.0473	CbGeAlD
Suramin—P2RX4—brain—narcolepsy	0.00973	0.0447	CbGeAlD
Suramin—PLA2G2A—midbrain—narcolepsy	0.0095	0.0436	CbGeAlD
Suramin—P2RY2—G alpha (q) signalling events—P2RY11—narcolepsy	0.00913	0.0117	CbGpPWpGaD
Suramin—SIRT1—brain—narcolepsy	0.00853	0.0392	CbGeAlD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00845	0.0108	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00845	0.0108	CbGpPWpGaD
Suramin—ARSA—brain—narcolepsy	0.00842	0.0387	CbGeAlD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00816	0.0104	CbGpPWpGaD
Suramin—RYR1—brain—narcolepsy	0.00788	0.0362	CbGeAlD
Suramin—P2RY2—G alpha (q) signalling events—HCRT—narcolepsy	0.00776	0.00992	CbGpPWpGaD
Suramin—PLA2G2A—Phospholipid metabolism—CHKB—narcolepsy	0.00759	0.00971	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00731	0.00934	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00731	0.00934	CbGpPWpGaD
Suramin—PLA2G4A—medulla oblongata—narcolepsy	0.00723	0.0332	CbGeAlD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00706	0.00902	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00706	0.00902	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00706	0.00902	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00694	0.00887	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—HCRTR1—narcolepsy	0.00689	0.00881	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—HCRTR2—narcolepsy	0.00689	0.00881	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00681	0.00871	CbGpPWpGaD
Suramin—F2—FOXA2 and FOXA3 transcription factor networks—CPT1B—narcolepsy	0.00664	0.00848	CbGpPWpGaD
Suramin—PLA2G4A—midbrain—narcolepsy	0.00661	0.0303	CbGeAlD
Suramin—SIRT5—Signaling events mediated by HDAC Class I—TNF—narcolepsy	0.00633	0.0081	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00626	0.008	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00626	0.008	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00605	0.00773	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00605	0.00773	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00605	0.00773	CbGpPWpGaD
Suramin—PLA2G2A—brain—narcolepsy	0.00597	0.0274	CbGeAlD
Suramin—P2RY2—G alpha (q) signalling events—TRH—narcolepsy	0.00588	0.00752	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00584	0.00746	CbGpPWpGaD
Suramin—FSHR—G alpha (s) signalling events—NPS—narcolepsy	0.00573	0.00733	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00526	0.00673	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00514	0.00657	CbGpPWpGaD
Suramin—PLA2G4A—Glycerophospholipid biosynthesis—CHKB—narcolepsy	0.00513	0.00656	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00496	0.00635	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HCRTR2—narcolepsy	0.00477	0.00609	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HCRTR1—narcolepsy	0.00477	0.00609	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HCRTR1—narcolepsy	0.0046	0.00589	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—P2RY11—narcolepsy	0.0046	0.00589	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HCRTR2—narcolepsy	0.0046	0.00589	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00458	0.00586	CbGpPWpGaD
Suramin—F2—brain—narcolepsy	0.00451	0.0207	CbGeAlD
Suramin—FSHR—GPCR ligand binding—P2RY11—narcolepsy	0.00445	0.00568	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00443	0.00566	CbGpPWpGaD
Suramin—FSHR—GPCRs, Other—HTR2A—narcolepsy	0.00442	0.00565	CbGpPWpGaD
Suramin—P2RY2—G alpha (q) signalling events—NPS—narcolepsy	0.00427	0.00546	CbGpPWpGaD
Suramin—P2RY2—G alpha (q) signalling events—TAC1—narcolepsy	0.00427	0.00546	CbGpPWpGaD
Suramin—PLA2G4A—brain—narcolepsy	0.00415	0.0191	CbGeAlD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00399	0.0051	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HCRT—narcolepsy	0.00391	0.005	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0039	0.00498	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00385	0.00492	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00382	0.00489	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00382	0.00489	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00379	0.00485	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HCRT—narcolepsy	0.00378	0.00483	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00376	0.00481	CbGpPWpGaD
Suramin—PLA2G4A—Phospholipid metabolism—CHKB—narcolepsy	0.00358	0.00457	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—PENK—narcolepsy	0.00349	0.00446	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00342	0.00437	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—PENK—narcolepsy	0.00337	0.00431	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0033	0.00422	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—NPS—narcolepsy	0.00311	0.00398	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—TRH—narcolepsy	0.00297	0.00379	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—TRH—narcolepsy	0.00287	0.00366	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00283	0.00362	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00283	0.00362	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00273	0.00349	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00273	0.00349	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0027	0.00345	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0027	0.00345	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00269	0.00344	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00269	0.00344	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00267	0.00341	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00267	0.00341	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—P2RY11—narcolepsy	0.00261	0.00333	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HCRTR2—narcolepsy	0.0026	0.00333	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HCRTR1—narcolepsy	0.0026	0.00333	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—P2RY11—narcolepsy	0.0026	0.00333	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HRH3—narcolepsy	0.0026	0.00333	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00258	0.0033	CbGpPWpGaD
Suramin—P2RY2—G alpha (q) signalling events—HTR2A—narcolepsy	0.00257	0.00329	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—P2RY11—narcolepsy	0.00251	0.00321	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HRH3—narcolepsy	0.00251	0.00321	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HCRTR1—narcolepsy	0.00245	0.00313	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HCRTR2—narcolepsy	0.00245	0.00313	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00245	0.00313	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00242	0.00309	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00242	0.00309	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—P2RY11—narcolepsy	0.00236	0.00302	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HCRTR2—narcolepsy	0.00236	0.00302	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HCRTR1—narcolepsy	0.00236	0.00302	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00233	0.00298	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0023	0.00294	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—P2RY11—narcolepsy	0.00228	0.00292	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—HCRT—narcolepsy	0.00222	0.00284	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HCRT—narcolepsy	0.00221	0.00283	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00219	0.0028	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—CTNNBL1—narcolepsy	0.00219	0.0028	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—NPS—narcolepsy	0.00216	0.00276	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—TAC1—narcolepsy	0.00216	0.00276	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HCRT—narcolepsy	0.00214	0.00273	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—NPS—narcolepsy	0.00208	0.00266	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—TAC1—narcolepsy	0.00208	0.00266	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HCRT—narcolepsy	0.00201	0.00257	CbGpPWpGaD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00199	0.00254	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00198	0.00254	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—PENK—narcolepsy	0.00197	0.00252	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—PENK—narcolepsy	0.00195	0.0025	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HCRT—narcolepsy	0.00194	0.00248	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00192	0.00245	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—PENK—narcolepsy	0.0019	0.00243	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class I—TNF—narcolepsy	0.00187	0.0024	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PENK—narcolepsy	0.00179	0.00229	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00179	0.00229	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00179	0.00229	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PENK—narcolepsy	0.00173	0.00221	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00173	0.00221	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0017	0.00218	CbGpPWpGaD
Suramin—ARSA—Metabolism—CHKB—narcolepsy	0.00169	0.00216	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—TRH—narcolepsy	0.00168	0.00215	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—TRH—narcolepsy	0.00168	0.00214	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00166	0.00212	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—TRH—narcolepsy	0.00166	0.00212	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00164	0.0021	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—TNF—narcolepsy	0.00163	0.00209	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—TRH—narcolepsy	0.00162	0.00207	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—TRH—narcolepsy	0.00152	0.00195	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0015	0.00192	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—TRH—narcolepsy	0.00147	0.00188	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HRH3—narcolepsy	0.00147	0.00188	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00147	0.00188	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HCRTR2—narcolepsy	0.00145	0.00185	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HCRTR1—narcolepsy	0.00145	0.00185	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HRH3—narcolepsy	0.00142	0.00182	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HCRTR1—narcolepsy	0.0014	0.00178	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HCRTR2—narcolepsy	0.0014	0.00178	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—P2RY11—narcolepsy	0.0014	0.00178	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HCRTR2—narcolepsy	0.00136	0.00174	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HCRTR1—narcolepsy	0.00136	0.00174	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—P2RY11—narcolepsy	0.00135	0.00172	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HRH3—narcolepsy	0.00133	0.00171	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—P2RY11—narcolepsy	0.00132	0.00168	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00131	0.00167	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—HTR2A—narcolepsy	0.0013	0.00166	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HRH3—narcolepsy	0.00129	0.00165	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—HTR2A—narcolepsy	0.00125	0.0016	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—TAC1—narcolepsy	0.00122	0.00156	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—NPS—narcolepsy	0.00122	0.00156	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—NPS—narcolepsy	0.00122	0.00156	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—TAC1—narcolepsy	0.00122	0.00156	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00121	0.00154	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—NPS—narcolepsy	0.00121	0.00154	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HCRT—narcolepsy	0.00119	0.00152	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—TAC1—narcolepsy	0.00118	0.0015	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—NPS—narcolepsy	0.00118	0.0015	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.00116	0.00149	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00115	0.00147	CbGpPWpGaD
Suramin—ARSA—Metabolism—CPT1B—narcolepsy	0.00115	0.00147	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HCRT—narcolepsy	0.00115	0.00147	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HCRT—narcolepsy	0.00112	0.00143	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00111	0.00142	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—NPS—narcolepsy	0.00111	0.00141	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—TAC1—narcolepsy	0.00111	0.00141	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00109	0.0014	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00109	0.0014	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CHKB—narcolepsy	0.00109	0.00139	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—TAC1—narcolepsy	0.00107	0.00137	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—NPS—narcolepsy	0.00107	0.00137	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PENK—narcolepsy	0.00106	0.00135	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PENK—narcolepsy	0.00102	0.00131	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—PENK—narcolepsy	0.000997	0.00127	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000976	0.00125	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—narcolepsy	0.000908	0.00116	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TRH—narcolepsy	0.000899	0.00115	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—TNF—narcolepsy	0.000893	0.00114	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TNF—narcolepsy	0.000886	0.00113	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TRH—narcolepsy	0.000869	0.00111	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—TRH—narcolepsy	0.000848	0.00108	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000839	0.00107	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000809	0.00103	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000809	0.00103	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HRH3—narcolepsy	0.000789	0.00101	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000783	0.001	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00077	0.000984	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00077	0.000984	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HRH3—narcolepsy	0.000762	0.000974	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—P2RY11—narcolepsy	0.000743	0.00095	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HRH3—narcolepsy	0.000743	0.00095	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CPT1B—narcolepsy	0.00074	0.000946	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—HTR2A—narcolepsy	0.000735	0.000939	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—HTR2A—narcolepsy	0.000733	0.000937	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TNF—narcolepsy	0.000727	0.000929	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—HTR2A—narcolepsy	0.000708	0.000905	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HCRTR2—narcolepsy	0.000699	0.000894	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HCRTR1—narcolepsy	0.000699	0.000894	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—P2RY11—narcolepsy	0.000675	0.000863	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HTR2A—narcolepsy	0.000665	0.000851	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000657	0.00084	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TAC1—narcolepsy	0.000653	0.000835	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NPS—narcolepsy	0.000653	0.000835	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HTR2A—narcolepsy	0.000643	0.000822	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HCRTR1—narcolepsy	0.000639	0.000817	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HCRTR2—narcolepsy	0.000639	0.000817	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HCRT—narcolepsy	0.000632	0.000808	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NPS—narcolepsy	0.000631	0.000807	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TAC1—narcolepsy	0.000631	0.000807	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—P2RY11—narcolepsy	0.000617	0.000789	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—TAC1—narcolepsy	0.000616	0.000787	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—NPS—narcolepsy	0.000616	0.000787	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—TNF—narcolepsy	0.000577	0.000738	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HCRT—narcolepsy	0.000574	0.000734	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PENK—narcolepsy	0.000563	0.00072	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HCRT—narcolepsy	0.000525	0.000671	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CHKB—narcolepsy	0.000513	0.000656	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PENK—narcolepsy	0.000512	0.000654	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000487	0.000622	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TRH—narcolepsy	0.000479	0.000612	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PENK—narcolepsy	0.000468	0.000598	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TRH—narcolepsy	0.000435	0.000556	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HRH3—narcolepsy	0.00042	0.000537	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HCRTR2—narcolepsy	0.000413	0.000528	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HCRTR1—narcolepsy	0.000413	0.000528	CbGpPWpGaD
Suramin—F2—Signaling Pathways—P2RY11—narcolepsy	0.000399	0.00051	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TRH—narcolepsy	0.000398	0.000509	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HTR2A—narcolepsy	0.000393	0.000503	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HRH3—narcolepsy	0.000381	0.000488	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HTR2A—narcolepsy	0.00038	0.000485	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HCRTR2—narcolepsy	0.000378	0.000483	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HCRTR1—narcolepsy	0.000378	0.000483	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HTR2A—narcolepsy	0.000371	0.000474	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—P2RY11—narcolepsy	0.000365	0.000466	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HRH3—narcolepsy	0.000349	0.000446	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CPT1B—narcolepsy	0.000349	0.000446	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TAC1—narcolepsy	0.000348	0.000445	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—NPS—narcolepsy	0.000348	0.000445	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HCRT—narcolepsy	0.000339	0.000434	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TAC1—narcolepsy	0.000316	0.000404	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NPS—narcolepsy	0.000316	0.000404	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HCRT—narcolepsy	0.00031	0.000396	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PENK—narcolepsy	0.000302	0.000386	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NPS—narcolepsy	0.000289	0.00037	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TAC1—narcolepsy	0.000289	0.00037	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000284	0.000363	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PENK—narcolepsy	0.000276	0.000353	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TRH—narcolepsy	0.000257	0.000329	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TRH—narcolepsy	0.000235	0.0003	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HRH3—narcolepsy	0.000225	0.000288	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR2A—narcolepsy	0.000209	0.000268	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HRH3—narcolepsy	0.000206	0.000263	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR2A—narcolepsy	0.00019	0.000243	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NPS—narcolepsy	0.000187	0.000239	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TAC1—narcolepsy	0.000187	0.000239	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR2A—narcolepsy	0.000174	0.000222	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TAC1—narcolepsy	0.000171	0.000218	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NPS—narcolepsy	0.000171	0.000218	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR2A—narcolepsy	0.000112	0.000144	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR2A—narcolepsy	0.000103	0.000131	CbGpPWpGaD
